Tudor Investment Corp’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Tudor Investment Corp’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,980	Closed	-$37K	–	1361
2018 Q3	$37K	Hold	10,980	–	–	﹤0.01%	1052
2018 Q2	$41K	Buy	+10,980	New	+$53.5K	﹤0.01%	1007
2016 Q3	–	Sell	-30,687	Closed	-$203K	–	1857
2016 Q2	$203K	Buy	30,687 +581	+2%	+$3.25K	﹤0.01%	1404
2016 Q1	$141K	Sell	30,106 -14,491	-32%	-$57.8K	﹤0.01%	1574
2015 Q4	$225K	Buy	44,597 +30,529	+217%	+$145K	0.01%	1387
2015 Q3	$50K	Buy	+14,068	New	+$94.2K	﹤0.01%	1476

Tudor Investment Corp's KERX Position: Q4 2018 in Review

Tudor Investment Corp sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 10,980 shares — an estimated $37K sold.

Tudor Investment Corp first reported a position in KERX in Q3 2015 and held it in 6 quarters. The position peaked at $225K in Q4 2015. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Tudor Investment Corp reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Tudor Investment Corp sold 10,980 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $37K.
Tudor Investment Corp first reported a position in Keryx Biopharmaceuticals Inc in Q3 2015 and held it in 6 quarters.
Tudor Investment Corp's Keryx Biopharmaceuticals Inc position peaked at $225K in Q4 2015.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Tudor Investment Corp's 13F filing for Q4 2018, filed 14 Feb 2019.